John P. Walker

2007 - Paratek Pharmaceuticals

In 2007, John P. Walker earned a total compensation of $4.7M as Chief Executive Officer of Novacea, Inc. through January 30, at Paratek Pharmaceuticals, a 2,480% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$193,750
Option Awards$2,947,456
Salary$319,391
Stock Awards$1,044,100
Other$204,264
Total$4,708,961

Walker received $2.9M in option awards, accounting for 63% of the total pay in 2007.

Walker also received $193.8K in non-equity incentive plan, $319.4K in salary, $1M in stock awards and $204.3K in other compensation.

Rankings

In 2007, John P. Walker's compensation ranked 880th out of 8,700 executives tracked by ExecPay. In other words, Walker earned more than 89.9% of executives.

ClassificationRankingPercentile
All
880
out of 8,700
90th
Division
Manufacturing
291
out of 3,314
91st
Major group
Chemicals And Allied Products
58
out of 746
92nd
Industry group
Drugs
35
out of 546
94th
Industry
Pharmaceutical Preparations
31
out of 364
92nd
Source: SEC filing on April 26, 2010.

Walker's colleagues

We found seven more compensation records of executives who worked with John P. Walker at Paratek Pharmaceuticals in 2007.

2007

Edward Albini

Paratek Pharmaceuticals

Chief Financial Officer

2007

Amar Singh

Paratek Pharmaceuticals

Chief Commercialization Officer

2007

Glenn Oclassen

Paratek Pharmaceuticals

Chief Executive Officer

2007

John Curd

Paratek Pharmaceuticals

Chief Medical Officer

2007

Nikhilesh Singh

Paratek Pharmaceuticals

Chief Scientific Officer

2007

Thomas Soloway

Paratek Pharmaceuticals

Chief Financial Officer

2007

Edward Schnipper

Paratek Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like